Abstract
Membrane receptors for blood proteases govern the clotting and fibrinolytic cascades, regulate signal transduction and control the growth of mesenchymal cells. Despite their importance in the development of vascular injury, it is unclear whether these mechanisms participate in the generation of an immune response. Here we report that targeting a factor Xa receptor, designated effector cell protease receptor-1 (EPR-1), with antisense oligonucleotide or with a monoclonal antibody (mAB 2E1) inhibited CD3/T-cell receptor-dependent lymphocyte proliferation. Immunosuppression was mediated by abolishing cytokine production and down-modulating membrane expression of the interleukin (IL)-2 receptor. In vivo administration of mAb 2E1 to severe-combined-immunodeficient mice injected with human peripheral blood leukocytes suppressed production of human immunoglobulin, abolished graft-versus-host disease, and protected these xenochimaeric mice from Epstein-Barr-virus-induced human lymphoproliferative disease. These observations indicate a new role for protease receptors in the regulation of the immune response, and identify a potential target for therapeutic immunosuppression in humans.
References
Apr 19, 1979·Nature·K C Glenn, D D Cunningham
Dec 1, 1992·The Journal of Experimental Medicine·M L VeroneseM Panozzo
Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G P GasicG J Gasic
Mar 22, 1991·Cell·T K VuS R Coughlin
Jan 16, 1992·Nature·M A DuchosalD R Burton
Jan 1, 1991·The Journal of Experimental Medicine·M RoweA B Rickinson
Oct 10, 1991·Nature·D E MosierD B Wilson
Oct 29, 1991·Biochemistry·E W DavieW Kisiel
Sep 1, 1990·The Journal of Experimental Medicine·M A DuchosalF J Dixon
Jun 1, 1987·European Journal of Immunology·C WalkerW J Pichler
Mar 16, 1989·Nature·D E MosierD B Wilson
Sep 15, 1988·Nature·D E MosierD B Wilson
Jul 1, 1985·Cell·L Patthy
Jul 30, 1993·Science·A ShahinianT W Mak
Jun 1, 1993·Current Opinion in Immunology·M K Jenkins, J G Johnson
Nov 5, 1993·Science·G J FreemanD B Lombard
Feb 24, 1995·Cell·T N StittP F Jones
May 1, 1994·Cellular Immunology·D C Altieri, S J Stamnes
Jun 1, 1993·Current Opinion in Immunology·C A Janeway, P Golstein
Apr 29, 1993·Nature·R Ross
Citations
Aug 14, 2001·Journal of Cellular Biochemistry·H C WuC T Lin
Jun 2, 1998·Kidney International·H HallerF C Luft
Feb 12, 2002·Shock·Toshiaki IbaTsuyoshi Hara
Dec 17, 1997·Cellular Immunology·S T SmileyM J Grusby
Jun 13, 2001·Biochemical and Biophysical Research Communications·A KawabataN Kawao
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·S T SmileyM J Grusby
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·A L Rothermel, D C Altieri
Oct 30, 2001·Transplant Immunology·X J ZuoS C Jordan
Jul 2, 2005·Expert Opinion on Emerging Drugs·Omer IqbalWilliam Wehrmacher
Jul 16, 2004·Kidney International·Malcolm A CunninghamStephen R Holdsworth
Jun 23, 2000·The Journal of Surgical Research·Y YamaguchiM Ogawa
Mar 28, 1996·Nature·M Trucco, G Stassi
Aug 16, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Karen E Welty-WolfClaude A Piantadosi
Apr 4, 1997·The Journal of Biological Chemistry·B A BouchardP B Tracy